Table 2.
Bleeding and spotting
|
Bleeding only
|
||||||||
---|---|---|---|---|---|---|---|---|---|
Mean (SE) | Median (range) | Mean difference | 95% CI of difference | p value | Mean (SE) Median (range) | Mean difference | 95% CI of difference | p value | |
First 84 days | |||||||||
Doxycycline group, n=32 | 14.75 (2.30) | 11.0 (0, 47) | −3.03 | −9.55, 3.49 | .36 | 5.00 (1.03) 3.0 (0, 20) | −2.16 | −5.51, 1.20 | .20 |
Placebo group, n=32 | 17.78 (2.31) | 17.0 (0, 48) | 7.15 (1.32) 4.0 (0, 28) | ||||||
Last 28 days | |||||||||
Doxycycline group, n=32 | 4.10 (1.23) | 0 (0, 28) | −3.81 | −7.46, 0.16 | .04 | 1.03 (0.34) 0.0 (0, 7) | −1.53 | −3.52, 0.46 | .13 |
Placebo group, n=32 | 7.91 (1.35) | 6.0 (0, 28) | 2.56 (0.94) 0.0 (0, 28) | ||||||
112 days | |||||||||
Doxycycline group, n=32 | 18.84 (3.30) | 12.0 (0, 63) | −6.84 | −16.08, 2.39 | .14 | 6.03 (1.21) 4.0 (0, 24) | −3.69 | −8.50, 1.13 | .13 |
Placebo group, n=32 | 25.69 (3.24) | 21.0 (0, 70) | 9.72 (2.08) 5.0 (0, 56) |